Weiguo Ye

Weiguo Ye

Chief Operating OfficeratGyre Therapeutics· In proxies 2022–2025

Pay in FY2025+1,410% from the year before · Gyre Therapeutics stock -41.7% the same year

Weiguo Ye was paid $5.0M in FY2025 (Dec), up 1,410%. Gyre Therapeutics stock fell 41.7% that year.

Pay$100 in the stock at the end of FY21 → $60
Pay is from the Summary Compensation Table of each Gyre Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Gyre TherapeuticsPublic company · 4 yr
    • Chief Operating Officer2022 – Present · 4 yrStock in role +196%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?